Clinical Trials Directory

Trials / Completed

CompletedNCT02366338

PRescriptiOn PattERns Of Oral Anticoagulants

PRescriptiOn PattERns Of Oral Anticoagulants in Non-valvular Atrial Fibrillation: A Single Center Experience From Turkey (PROPER)

Status
Completed
Phase
Study type
Observational
Enrollment
148 (actual)
Sponsor
Muğla Sıtkı Koçman University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Atrial fibrillation is the major cause of acute ischemic stroke. The risk of stroke was shown to decline by oral anticoagulant therapy. The investigators intended to evaluate appropriate use of anticoagulants in non-valvular AF patients.

Detailed description

Atrial fibrillation, the most common sustained arrhythmia, is the major cause of acute ischemic stroke. The prognosis of ischemic stroke associated with atrial fibrillation (AF) tends to have a worse prognosis for recovery compared with other ischemic stroke subtypes. The risk of stroke was shown to decline to 68% by oral anticoagulant (OAC) therapy.The investigators have evaluated appropriate use of anticoagulants in non-valvular AF patients. Appropriate use of oral anticoagulants was assessed by Medication Appropriateness Index (MAI). The MAI consists of 10 criteias namely, indication, choice, dosage, modalities and practicability of administration, drug-drug interactions, drug-disease interactions, duplication, duration, and cost-effectiveness. The tenth criteria was not evaluated because of limited data regarding cost-effectiveness of the drugs.

Conditions

Timeline

Start date
2014-08-01
Primary completion
2014-11-01
Completion
2014-11-01
First posted
2015-02-19
Last updated
2015-05-21
Results posted
2015-05-21

Source: ClinicalTrials.gov record NCT02366338. Inclusion in this directory is not an endorsement.